Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major
暂无分享,去创建一个
Jason A. Papin | James A. Eddy | Arvind K. Chavali | Jeffrey D Whittemore | Kyle T Williams | J. Papin
[1] S. Wakil,et al. THE MECHANISM OF FATTY ACID SYNTHESIS. , 1960, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Simpson,et al. Isolation and characterization of kinetoplast DNA from Leishmania tarentolae. , 1971, Journal of molecular biology.
[3] M. Vessal,et al. Leishmania species: fatty acid composition of promastigotes. , 1974, Experimental parasitology.
[4] D. Beach,et al. Lipids of Leishmania promastigotes. , 1979, The Journal of parasitology.
[5] U. Bachrach,et al. Leishmania spp.: cellular levels and synthesis of polyamines during growth cycles. , 1979, Experimental parasitology.
[6] U. Bachrach,et al. Leishmania spp.: effect of inhibitors on growth and on polyamine and macromolecular syntheses. , 1979, Experimental parasitology.
[7] Polyamines and the growth of leishmanial parasites. , 1981, Medical biology.
[8] K. Stuart. Kinetoplast DNA, mitochondrial DNA with a difference. , 1983, Molecular and biochemical parasitology (Print).
[9] K. Stuart. Kinetoplast DNA, mitochondria DNA with a difference , 1983 .
[10] D. Rowe,et al. The Special Programme for Research and Training in Tropical Diseases , 1984 .
[11] F. Opperdoes,et al. The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species. , 1984, Molecular and biochemical parasitology.
[12] B. Chait,et al. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. , 1985, Science.
[13] David H. Molyneux,et al. Morphology, ultrastructure and life cycles. , 1987 .
[14] D. G. Davis,et al. Products of Leishmania braziliensis glucose catabolism: release of D-lactate and, under anaerobic conditions, glycerol. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Remaley,et al. Biochemistry of the Leishmania species. , 1988, Microbiological reviews.
[16] P. Hellung-Larsen,et al. Cell volume and dry weight of cultured Tetrahymena. , 1989, Journal of cell science.
[17] C. Wang,et al. Evolutionary conservation of a microbody targeting signal that targets proteins to peroxisomes, glyoxysomes, and glycosomes , 1991, The Journal of cell biology.
[18] A. Fairlamb,et al. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. , 1992, The Biochemical journal.
[19] F. Opperdoes,et al. Comparative physiology of two protozoan parasites, Leishmania donovani and Trypanosoma brucei, grown in chemostats , 1992, Journal of bacteriology.
[20] F. Opperdoes,et al. The glycosomes of the Kinetoplastida. , 1993, Biochimie.
[21] B. Palsson,et al. Metabolic Capabilities of Escherichia coli II. Optimal Growth Patterns , 1993 .
[22] B. Palsson,et al. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110 , 1994, Applied and environmental microbiology.
[23] Amit Varma,et al. Parametric sensitivity of stoichiometric flux balance models applied to wild‐type Escherichia coli metabolism , 1995, Biotechnology and bioengineering.
[24] Martin Olivier,et al. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages , 1997, The EMBO journal.
[25] H. Hwang,et al. Genetic Analysis of Purine Metabolism in Leishmania donovani * , 1997, The Journal of Biological Chemistry.
[26] H. Ikenaga,et al. Functional Evidence for UDP-galactose Transporter inSaccharomyces cerevisiae through the in Vivo Galactosylation and in Vitro Transport Assay* , 1998, The Journal of Biological Chemistry.
[27] A. Fairlamb,et al. Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus , 1998, Molecular microbiology.
[28] P. Myler,et al. Xanthine Phosphoribosyltransferase from Leishmania donovani , 1999, The Journal of Biological Chemistry.
[29] D. Sereno,et al. Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms. , 1999, The American journal of tropical medicine and hygiene.
[30] A. Fairlamb,et al. Ornithine Decarboxylase Gene Deletion Mutants of Leishmania donovani * , 1999, The Journal of Biological Chemistry.
[31] Barbara M. Bakker,et al. Compartmentation protects trypanosomes from the dangerous design of glycolysis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] B. Palsson,et al. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Fairlamb,et al. The structure of reduced tryparedoxin peroxidase reveals a decamer and insight into reactivity of 2Cys-peroxiredoxins. , 2000, Journal of molecular biology.
[34] A. Fairlamb,et al. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress , 2000, Molecular microbiology.
[35] F. Hidalgo-Zarco,et al. Trypanosomal dUTPases as potential targets for drug design. , 2001, Current protein & peptide science.
[36] N. Carter,et al. Genetic analysis of spermidine synthase from Leishmania donovani. , 2001, Molecular and biochemical parasitology.
[37] Ming Chen,et al. Inhibition of Fumarate Reductase inLeishmania major and L. donovani by Chalcones , 2001, Antimicrobial Agents and Chemotherapy.
[38] T. Ilg,et al. Disruption of mannose activation in Leishmania mexicana: GDP‐mannose pyrophosphorylase is required for virulence, but not for viability , 2001, The EMBO journal.
[39] Thomas Ilg,et al. The Role of Phosphomannose Isomerase in Leishmania mexicana Glycoconjugate Synthesis and Virulence* , 2001, The Journal of Biological Chemistry.
[40] J. Concepción,et al. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. , 2002, Molecular and biochemical parasitology.
[41] Fabio Zicker,et al. Strategic emphases for tropical diseases research: a TDR perspective. , 2002, Trends in parasitology.
[42] W. de Souza. Special organelles of some pathogenic protozoa , 2002, Parasitology research.
[43] J. Sullivan,et al. Cultivation of Clinically Significant Hemoflagellates , 2002, Clinical Microbiology Reviews.
[44] J. Donelson,et al. The Genome of the African Trypanosome , 2002 .
[45] G. Church,et al. Genome-Scale Metabolic Model of Helicobacter pylori 26695 , 2002, Journal of bacteriology.
[46] Michael A. J. Ferguson,et al. Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Fairlamb,et al. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead , 2002, Amino Acids.
[48] André Schneider,et al. Mitochondrial Substrate Level Phosphorylation Is Essential for Growth of Procyclic Trypanosoma brucei * , 2002, The Journal of Biological Chemistry.
[49] N. Carter,et al. S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers. , 2002, The Journal of biological chemistry.
[50] M. McConville,et al. Evidence That Intracellular β1-2 Mannan Is a Virulence Factor in Leishmania Parasites* , 2003, Journal of Biological Chemistry.
[51] B. Palsson,et al. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR) , 2003, Genome Biology.
[52] J. Urbina,et al. Specific chemotherapy of Chagas disease: controversies and advances. , 2003, Trends in parasitology.
[53] Kenneth J. Kauffman,et al. Advances in flux balance analysis. , 2003, Current opinion in biotechnology.
[54] R. Krauth-Siegel,et al. The Parasite-Specific Trypanothione Metabolism of Trypanosoma and Leishmania , 2003, Biological chemistry.
[55] Sean Thomas,et al. Transcription in kinetoplastid protozoa: why be normal? , 2003, Microbes and infection.
[56] F. Hsu,et al. Sphingolipids are essential for differentiation but not growth in Leishmania , 2003, The EMBO journal.
[57] S. Beverley. Protozomics: trypanosomatid parasite genetics comes of age , 2003, Nature Reviews Genetics.
[58] F. Opperdoes,et al. Evolution of energy metabolism and its compartmentation in Kinetoplastida , 2003, Kinetoplastid biology and disease.
[59] B. Palsson,et al. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. , 2003, Genome research.
[60] S. Croft,et al. Leishmaniasis: new approaches to disease control , 2003, BMJ : British Medical Journal.
[61] Philippe Diolez,et al. ATP Generation in the Trypanosoma brucei Procyclic Form , 2003, Journal of Biological Chemistry.
[62] Daniel J Rigden,et al. Kinetic characterization, structure modelling studies and crystallization of Trypanosoma brucei enolase. , 2003, European journal of biochemistry.
[63] M. Gates,et al. Dry to wet weight biomass conversion constant for Tetrahymena elliotti (Ciliophora, Protozoa) , 1982, Oecologia.
[64] W. de Souza,et al. Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. , 2004, International journal of antimicrobial agents.
[65] A. Danchin,et al. Bacterial variations on the methionine salvage pathway , 2004, BMC Microbiology.
[66] G. Stormo,et al. Expression profiling using random genomic DNA microarrays identifies differentially expressed genes associated with three major developmental stages of the protozoan parasite Leishmania major. , 2004, Molecular and biochemical parasitology.
[67] K. Gibson,et al. Arginase Plays a Pivotal Role in Polyamine Precursor Metabolism in Leishmania , 2004, Journal of Biological Chemistry.
[68] David M. A. Martin,et al. The Genome of the African Trypanosome Trypanosoma brucei , 2005, Science.
[69] Heather J Munden,et al. The Genome of the Kinetoplastid Parasite, Leishmania major , 2005, Science.
[70] T. Smith,et al. The myo-inositol-1-phosphate synthase gene is essential in Trypanosoma brucei. , 2005, Biochemical Society Transactions.
[71] B. Palsson,et al. Expanded Metabolic Reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an In Silico Genome-Scale Characterization of Single- and Double-Deletion Mutants , 2005, Journal of bacteriology.
[72] J. Nielsen,et al. From genomes to in silico cells via metabolic networks. , 2005, Current opinion in biotechnology.
[73] Y. Shouche,et al. Molecular Characterization of the Hexokinase Gene From Leishmania major , 2005, The Journal of parasitology.
[74] A. Schnaufer,et al. The F1‐ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function , 2005, The EMBO journal.
[75] Peter Rohloff,et al. Acidocalcisomes ? conserved from bacteria to man , 2005, Nature Reviews Microbiology.
[76] C. Francke,et al. Reconstructing the metabolic network of a bacterium from its genome. , 2005, Trends in microbiology.
[77] B. Palsson,et al. Systems approach to refining genome annotation , 2006, Proceedings of the National Academy of Sciences.
[78] M. Lipoldová,et al. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis , 2006, Nature Reviews Genetics.
[79] Erwin P. Gianchandani,et al. Flux balance analysis in the era of metabolomics , 2006, Briefings Bioinform..
[80] B. Palsson,et al. Towards multidimensional genome annotation , 2006, Nature Reviews Genetics.
[81] R. Panizzutti,et al. The occurrence of free D-alanine and an alanine racemase activity in Leishmania amazonensis. , 2006, FEMS microbiology letters.
[82] C. Forst. Host-pathogen systems biology. , 2006, Drug discovery today.
[83] M. McConville,et al. Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[84] B. Ullman,et al. Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages. , 2006, Molecular and biochemical parasitology.
[85] Adam M. Feist,et al. Modeling methanogenesis with a genome‐scale metabolic reconstruction of Methanosarcina barkeri , 2006 .
[86] Samuel H. Payne,et al. Retention and Loss of Amino Acid Biosynthetic Pathways Based on Analysis of Whole-Genome Sequences , 2006, Eukaryotic Cell.
[87] Jean-Pierre Szikora,et al. In silico prediction of the glycosomal enzymes of Leishmania major and trypanosomes. , 2006, Molecular and biochemical parasitology.
[88] Adam M. Feist,et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information , 2007, Molecular systems biology.
[89] H. Bussey,et al. Exploring genetic interactions and networks with yeast , 2007, Nature Reviews Genetics.
[90] K. Leifso,et al. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. , 2007, Molecular and biochemical parasitology.
[91] P. T. Englund,et al. A fatty-acid synthesis mechanism specialized for parasitism , 2007, Nature Reviews Microbiology.
[92] Bernhard O. Palsson,et al. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets , 2007 .
[93] Y. Pérez-Pertejo,et al. S-Adenosylmethionine in protozoan parasites: functions, synthesis and regulation. , 2007, Molecular and biochemical parasitology.
[94] Jong Myoung Park,et al. Genome-scale analysis of Mannheimia succiniciproducens metabolism. , 2007, Biotechnology and bioengineering.
[95] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[96] Sumana Sanyal,et al. De Novo Sphingolipid Synthesis Is Essential for Viability, but Not for Transport of Glycosylphosphatidylinositol-Anchored Proteins, in African Trypanosomes , 2007, Eukaryotic Cell.
[97] F. Opperdoes,et al. The metabolic repertoire of Leishmania and implications for drug discovery , 2008 .
[98] Jason A. Papin,et al. * Corresponding authors , 2006 .